Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: A randomized, double-blind, placebo-controlled, multiple-dose study in adult patients with type 2 diabetes
Covington, Paul, MD, Christopher, Ronald, PhD, Davenport, Michael, PhD, Fleck, Penny, MT, Mekki, Qais A., MD, PhD, Wann, Elisabeth R., PhD, Karim, Aziz, PhD
Published in Clinical therapeutics (01.03.2008)
Published in Clinical therapeutics (01.03.2008)
Get full text
Journal Article
Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects
Christopher, Ronald, PhD, Covington, Paul, MD, Davenport, Michael, PhD, Fleck, Penny, MT, Mekki, Qais A., MD, PhD, Wann, Elisabeth R., PhD, Karim, Aziz, PhD
Published in Clinical therapeutics (01.03.2008)
Published in Clinical therapeutics (01.03.2008)
Get full text
Journal Article